We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.38B
AUM Growth
-$459M
Cap. Flow
-$743M
Cap. Flow %
-31.14%
Top 10 Hldgs %
33.74%
Holding
419
New
42
Increased
61
Reduced
145
Closed
52

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$59.1M
2
PGR icon
Progressive
PGR
+$57.1M
3
EL icon
Estee Lauder
EL
+$40.6M
4
META icon
Meta Platforms (Facebook)
META
+$33.8M
5
AAPL icon
Apple
AAPL
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 34.34%
2 Healthcare 16.07%
3 Consumer Discretionary 11.28%
4 Communication Services 10.91%
5 Industrials 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSBC icon
201
Great Southern Bancorp
GSBC
$874M
$193K 0.01%
3,047
PFC
202
DELISTED
Premier Financial Corp. Common Stock
PFC
$193K 0.01%
6,142
MED icon
203
Medifast
MED
$135M
$185K 0.01%
1,684
-9,238
-85% -$894K
WTI icon
204
W&T Offshore
WTI
$577M
$184K 0.01%
33,176
IPAR icon
205
Interparfums
IPAR
$3.83B
$183K 0.01%
2,520
-100
-4% -$7.28K
ACH
206
Accendra Health
ACH
$107M
$179K 0.01%
34,580
TPCO
207
DELISTED
Tribune Publishing Company Common Stock
TPCO
$175K 0.01%
13,278
UFPT icon
208
UFP Technologies
UFPT
$2.52B
$172K 0.01%
3,470
WRLD icon
209
World Acceptance Corp
WRLD
$871M
$167K 0.01%
1,930
CIR
210
DELISTED
CIRCOR International, Inc
CIR
$166K 0.01%
3,590
ANGO icon
211
AngioDynamics
ANGO
$651M
$164K 0.01%
10,251
MIXT
212
DELISTED
MIX TELEMATICS LIMITED
MIXT
$164K 0.01%
12,671
MEET
213
DELISTED
The Meet Group, Inc. Common Stock
MEET
$163K 0.01%
+32,518
New +$153K
ACAD icon
214
Acadia Pharmaceuticals
ACAD
$5.06B
$162K 0.01%
3,790
-300
-7% -$13.1K
GBT
215
DELISTED
Global Blood Therapeutics, Inc.
GBT
$159K 0.01%
2,000
PGR icon
216
Progressive
PGR
$124B
$158K 0.01%
2,179
-791,672
-100% -$57.1M
GTS
217
DELISTED
Triple-S Management Corporation
GTS
$156K 0.01%
8,424
HZNP
218
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$152K 0.01%
4,210
BPMC
219
DELISTED
Blueprint Medicines
BPMC
$151K 0.01%
1,890
SANM icon
220
Sanmina
SANM
$10.7B
$151K 0.01%
4,400
NIC icon
221
Nicolet Bankshares
NIC
$3.63B
$148K 0.01%
2,000
BRK.B icon
222
Berkshire Hathaway Class B
BRK.B
$1.13T
$145K 0.01%
641
+40
+7% +$8.69K
FCN icon
223
FTI Consulting
FCN
$4.17B
$141K 0.01%
1,270
-100
-7% -$10.9K
RGEN icon
224
Repligen
RGEN
$9.21B
$138K 0.01%
1,490
APYX icon
225
Apyx Medical
APYX
$146M
$137K 0.01%
16,200

Similar funds

Smith Group Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Smith Group Asset Management held 419 positions worth $2.38B, down 16% from $2.84B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Smith Group Asset Management withdrew a net $743M in Q4 2019, closing 52 positions and reducing 145 holdings. Its most notable exit was Estee Lauder, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Smith Group Asset Management opened a new position in Edwards Lifesciences worth $30.9M.

  • Smith Group Asset Management's largest Q4 2019 buy was Edwards Lifesciences: 397,005 shares worth $30.9M.
  • Smith Group Asset Management added most to Huntington Ingalls Industries in Q4 2019, an estimated $18.2M increase.
  • Smith Group Asset Management's biggest Q4 2019 reduction was Microsoft, cutting an estimated $59.1M.
  • Smith Group Asset Management fully exited Estee Lauder in Q4 2019, selling an estimated $40.6M.
  • Smith Group Asset Management's ten largest holdings make up 34% of its $2.38B portfolio in Q4 2019.
  • Smith Group Asset Management opened 42 new positions and closed 52 in Q4 2019.
  • Smith Group Asset Management's portfolio value fell 16% quarter-over-quarter to $2.38B.

Based on Smith Group Asset Management's 13F filing for Q4 2019, filed 4 Feb 2020.